Are health systems turning to Big Tech for digital health? Healthcare providers have specific software investment priorities for the next year. We explore if Big Tech players’ digital health capabilities are meeting those needs.

How price transparency regulations are impacting consumers: Patients aren’t shopping around for costs of healthcare services even as payers and providers are required to post prices—but that could change amid economic pressures.

In an era of uncertainty, healthcare providers still buy tech: Most hospitals and health systems aren’t pressing pause on software investments. We analyze what’s driving the spending and where the money is going.

Are smart TVs the new telehealth frontier? Consumer electronics giants like Samsung are getting in on the shift to home-based healthcare with telehealth integrations.

Seniors are bearish on retail health: Younger consumers are more likely than older ones to try out retail health clinics. We explore how retailers can step up to reach more seniors.

Walgreens doubles down on home health: The pharmacy chain is racing CVS and other rivals to dominate the surging home healthcare sector.

Mark Cuban’s online pharmacy shifts business strategy: We explore Cost Plus Drugs’ first collaborations with a PBM and health plan and analyze why the pharmacy decided to pivot away from operating all on its own.

Telehealth exposure helps patients stay attentive to their care: We dive into study findings comparing the quality of in-person care with virtual and analyze how the rosy results for telehealth could impact future policies.

A West Health-Gallup report shows citizens rate their healthcare system as C+ at best. We unpack the grades for access, cost, equity, and quality.

We combed through Kaufman Hall’s 2022 State of the Healthcare Consumer Report. We’ll detail emerging trends that highlight how consumers are managing their own health.

Patients give telehealth rave reviews: We look at new data from JD Power and unpack what’s driving consumer use and satisfaction

At the end of the day, we think the value of Hims & Hers’ new sex report lies more in the titillating topic than the novelty of its findings.

Primary care disruptors could reel in patients with $0 telehealth: We unpack Blue Cross MA’s new tie-up with Carbon and Health and Firefly Health and explain why consumers will ultimately benefit.

Zooming in on young Hispanics and healthcare: We look at the US Hispanic population’s attitudes toward healthcare and what providers and marketers need to do to get the younger generation engaged.

Humana, CVS battle for Cano Health: We unpack why the two companies are going after primary care disruptor Cano, and posit which player might have the upper hand.

Smartwatches and fitness trackers face slump: Rising inflation, economic uncertainty, and slowing innovation are ending pandemic-era hyper-growth as the segment matures.

Meta tries to skirt around ATT: A lawsuit alleges that the social media giant injected tracking code into its in-app browsers, breaking privacy rules.

Nvidia’s new edge AI computing platform highlights the need to protect surgical robots and medical devices from hacking.

Pfizer expands its agreement with CytoReason by five years to boost AI’s role in drug development. We spotlight the trend in the pharma world.